PMC Links for Books (Select 5114436) - PMC

Select item 75051211.

Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer Retrospective Analyses of the CRYSTAL and FIRE-3 Trials

Sabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello, Josep Tabernero, Eric Van Cutsem, Frank Beier, Regina Esser, Heinz-Josef Lenz, Volker Heinemann

JAMA Oncol. Author manuscript; available in PMC 2020 Sep 21.

Published in final edited form as: JAMA Oncol. 2017 Feb 1; 3(2): 194–201. doi: 10.1001/jamaoncol.2016.3797

PMCID:: PMC7505121

Abstract Article PDF–615K

Select item 75009672.

Neoadjuvant Chemotherapy without Radiation in Colorectal Cancer

Jyotsna Bhudia, Rob Glynne-Jones, Thomas Smith, Marcia Hall

Clin Colon Rectal Surg. 2020 Sep; 33(5): 287–297. Published online 2020 Jul 25. doi: 10.1055/s-0040-1713746

PMCID:: PMC7500967

Abstract Article PDF–251K

Select item 73706993.

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study

Eric Van Cutsem, Sanne Huijberts, Axel Grothey, Rona Yaeger, Pieter-Jan Cuyle, Elena Elez, Marwan Fakih, Clara Montagut, Marc Peeters, Takayuki Yoshino, Harpreet Wasan, Jayesh Desai, Fortunato Ciardiello, Ashwin Gollerkeri, Janna Christy-Bittel, Kati Maharry, Victor Sandor, Jan H.M. Schellens, Scott Kopetz, Josep Tabernero

J Clin Oncol. 2019 Jun 10; 37(17): 1460–1469. Published online 2019 Mar 20. doi: 10.1200/JCO.18.02459

PMCID:: PMC7370699

Abstract Article PDF–875K

Select item 72605824.

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

Giandomenico Roviello, Alberto D'Angelo, Roberto Petrioli, Franco Roviello, Fabio Cianchi, Stefania Nobili, Enrico Mini, Daniele Lavacchi

Transl Oncol. 2020 Sep; 13(9): 100795. Published online 2020 May 26. doi: 10.1016/j.tranon.2020.100795

PMCID:: PMC7260582

Abstract Article PDF–651K

Select item 71249475.

Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline

E. Gabriela Chiorean, Govind Nandakumar, Temidayo Fadelu, Sarah Temin, Ashley Efrain Alarcon-Rozas, Suyapa Bejarano, Adina-Emilia Croitoru, Surbhi Grover, Pritesh V. Lohar, Andrew Odhiambo, Se Hoon Park, Erika Ruiz Garcia, Catherine Teh, Azmina Rose, Bassem Zaki, Mary D. Chamberlin

JCO Glob Oncol. 2020; 6: JGO.19.00367. Published online 2020 Mar 9. doi: 10.1200/JGO.19.00367

PMCID:: PMC7124947

Abstract Article PDF–740K

Select item 67782916.

Molecular Profiling of EGFR Status to Identify Skin Toxicity in Colorectal Cancer: A Clinicopathological Review

CM POPA, C LUNGULESCU, SL IANOȘI, I CHERCIU, M SCHENKER, A SĂFTOIU

Curr Health Sci J. 2019 Apr-Jun; 45(2): 127–133. Published online 2019 Jun 30. doi: 10.12865/CHSJ.45.02.01

PMCID:: PMC6778291

Abstract Article

Select item 67383567.

Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab

Claus-Henning Köhne, Meinolf Karthaus, Laurent Mineur, Josef Thaler, Marc Van den Eynde, Javier Gallego, Reija Koukakis, Marloes Berkhout, Ralf-Dieter Hofheinz

Drugs R D. 2019 Sep; 19(3): 267–275. Published online 2019 Jul 12. doi: 10.1007/s40268-019-0278-8

PMCID:: PMC6738356

Abstract Article PDF–803K

Select item 61354668.

RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine

Anna M. Valentini, Elisabetta Cavalcanti, Marianna Di Maggio, Maria L. Caruso

Appl Immunohistochem Mol Morphol. 2018 Sep; 26(8): 539–544. Published online 2017 Jan 2. doi: 10.1097/PAI.0000000000000475

PMCID:: PMC6135466

Abstract Article PDF–292K

Select item 60681729.

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials

Marc Peeters, Timothy Price, Julien Taieb, Michael Geissler, Fernando Rivera, Jean-Luc Canon, George Pentheroudakis, Reija Koukakis, Peter Burdon, Salvatore Siena

Br J Cancer. 2018 Aug 1; 119(3): 303–312. Published online 2018 Jul 17. doi: 10.1038/s41416-018-0165-z

PMCID:: PMC6068172

Abstract Article PDF–449K

Select item 587019710.

FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer

Caglayan Geredeli, Nurgul Yasar

World J Surg Oncol. 2018; 16: 67. Published online 2018 Mar 27. doi: 10.1186/s12957-018-1359-9

PMCID:: PMC5870197

Abstract Article PDF–585K

Select item 583361811.

Association of Primary Tumor Site With Mortality in Patients Receiving Bevacizumab and Cetuximab for Metastatic Colorectal Cancer

Mayada A. Aljehani, John W. Morgan, Laurel A. Guthrie, Brice Jabo, Majed Ramadan, Khaled Bahjri, Sharon S. Lum, Matthew Selleck, Mark E. Reeves, Carlos Garberoglio, Maheswari Senthil

JAMA Surg. 2018 Jan; 153(1): 60–67. Published online 2017 Sep 20. doi: 10.1001/jamasurg.2017.3466

PMCID:: PMC5833618

Abstract Article

Select item 580094012.

Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients

Surajit Pathak, Sushmitha S, Antara Banerjee, Francesco Marotta, Madhumala Gopinath, Ramachandran Murugesan, Hong Zhang, Bhavani B, Agnishwar Girigoswami, Jose Sollano, Xiao-Feng Sun

Oncotarget. 2018 Jan 26; 9(7): 7739–7748. Published online 2017 Nov 16. doi: 10.18632/oncotarget.22471

PMCID:: PMC5800940

Abstract Article PDF–2.2M

Select item 568045713.

Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study

Eiji Shinozaki, Takayuki Yoshino, Kentaro Yamazaki, Kei Muro, Kensei Yamaguchi, Tomohiro Nishina, Satoshi Yuki, Kohei Shitara, Hideaki Bando, Sachiyo Mimaki, Chikako Nakai, Koutatsu Matsushima, Yutaka Suzuki, Kiwamu Akagi, Takeharu Yamanaka, Shogo Nomura, Satoshi Fujii, Hiroyasu Esumi, Masaya Sugiyama, Nao Nishida, Masashi Mizokami, Yasuhiro Koh, Yukiko Abe, Atsushi Ohtsu, Katsuya Tsuchihara

Br J Cancer. 2017 Nov 7; 117(10): 1450–1458. Published online 2017 Oct 3. doi: 10.1038/bjc.2017.308

PMCID:: PMC5680457

Abstract Article PDF–523K

Select item 553601214.

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

Alessia Bignucolo, Elena De Mattia, Erika Cecchin, Rossana Roncato, Giuseppe Toffoli

Int J Mol Sci. 2017 Jul; 18(7): 1522. Published online 2017 Jul 14. doi: 10.3390/ijms18071522

PMCID:: PMC5536012

Abstract Article PDF–878K

Select item 510489915.

Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer

Meinolf Karthaus, Ralf-Dieter Hofheinz, Laurent Mineur, Henry Letocha, Richard Greil, Josef Thaler, Eva Fernebro, Kelly S Oliner, Michael Boedigheimer, Brian Twomey, Ying Zhang, Gaston Demonty, Claus-Henning Köhne

Br J Cancer. 2016 Nov 8; 115(10): 1215–1222. Published online 2016 Oct 20. doi: 10.1038/bjc.2016.343

PMCID:: PMC5104899

Abstract Article PDF–457K

Select item 467322916.

Markus Morkel, Pamela Riemer, Hendrik Bläker, Christine Sers

Oncotarget. 2015 Aug 28; 6(25): 20785–20800. Published online 2015 Jul 30. doi: 10.18632/oncotarget.4750

PMCID:: PMC4673229

Abstract Article PDF–1.8M

Select item 396656417.

PharmGKB Summary: Very Important Pharmacogene Information for Epidermal Growth Factor Receptor (EGFR)

Ugur Hodoglugil, Michelle W. Carrillo, Joan M. Hebert, Niki Karachaliou, Rafael C. Rosell, Russ B. Altman, Teri E. Klein

Pharmacogenet Genomics. Author manuscript; available in PMC 2014 Mar 26.

Published in final edited form as: Pharmacogenet Genomics. 2013 Nov; 23(11): 636–642. doi: 10.1097/FPC.0b013e3283655091

PMCID:: PMC3966564

Article PDF–53K

Select item 314649018.

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

Filip Janku, J. Jack Lee, Apostolia M. Tsimberidou, David S. Hong, Aung Naing, Gerald S. Falchook, Siqing Fu, Rajyalakshmi Luthra, Ignacio Garrido-Laguna, Razelle Kurzrock

PLoS One. 2011; 6(7): e22769. Published online 2011 Jul 29. doi: 10.1371/journal.pone.0022769

PMCID:: PMC3146490

Abstract Article PDF–487K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 18

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity